{"title":"Pembrolizumab可增强食管胃癌的现有治疗方法","authors":"","doi":"10.1158/2159-8290.CD-RW2020-079","DOIUrl":null,"url":null,"abstract":"Anti-PD-1 was safe to add to anti-HER2 plus chemotherapy in HER2-positive esophagogastric cancers.","PeriodicalId":502270,"journal":{"name":"Cancer Discovery","volume":"3 2","pages":"901"},"PeriodicalIF":0.0000,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pembrolizumab May Enhance Current Treatments for Esophagogastric Cancers.\",\"authors\":\"\",\"doi\":\"10.1158/2159-8290.CD-RW2020-079\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Anti-PD-1 was safe to add to anti-HER2 plus chemotherapy in HER2-positive esophagogastric cancers.\",\"PeriodicalId\":502270,\"journal\":{\"name\":\"Cancer Discovery\",\"volume\":\"3 2\",\"pages\":\"901\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Discovery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/2159-8290.CD-RW2020-079\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/2159-8290.CD-RW2020-079","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
